The global vision care market reached a value of US$ 58.83 Billion in 2018. Vision care refers to the process of maintaining the overall functioning and quality of the eyes. Healthy eyesight is necessary for proper brain functioning as optimum vision helps an individual in carrying out different activities. Over the years, the number of vision ailments, such as cataract, glaucoma, conjunctivitis and retinal detachment, has increased significantly due to sedentary lifestyles, growing geriatric population and rising pollution levels. This has led to the development and production of various medicines in the form of pills, ointments and drops. In order to prevent these diseases, people get vision tests regularly, including visual field test for peripheral vision, visual acuity screening for measuring distance vision and tonometry for detecting glaucoma.
In recent years, there has been an improvement in the prevention of visual impairments with the advent of advanced technologies, along with the availability of experienced surgeons and practitioners. New treatments, such as gene therapy, computerized eye evaluations and stem cell therapy, have proven to be effective measures in the vision care industry. Some of the other technological advancements that have been introduced for ophthalmologists include selective laser trabeculoplasty, diode or argon laser, and wave-front analysis. Furthermore, owing to the rising prevalence of vision ailments, governmental and non-governmental organizations across the globe, especially in developing regions, have been undertaking initiatives to spread awareness about the availability of appropriate treatments and therapies. For instance, a pilot project has been implemented in India by the not-for-profit organization, India Vision Institute (IVI), and the Czech Republic-based start-up, DOT Glasses. The project focusses on the provision of vision screening access to the underprivileged and the prevention of avoidable blindness across the country. According to IMARC Group, the market is projected to reach a value of US$ 70.52 Billion by 2024, at a projected CAGR of around 2.96% during 2019-2024.
Breakup by Product Type:
At present, glass lenses are mostly preferred by consumers across the globe.
Breakup by Distribution Channel:
Retail stores are the most popular distribution channel in the market.
North America currently represents the biggest market for vision care, accounting for the majority of the total market share.
The report has also analyzed the competitive landscape of the market, with some of the key players being Johnson & Johnson Services, Inc., CooperVision, Inc. (Cooper Companies, Inc.), Bausch Health Companies Inc., Essilor International, and Novartis International AG.
Key Questions Answered in This Report:
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-702-409-7331 )
( India: +91-120-433-0800 )
Drop us an email at